| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/26/2001 | EP1135390A1 Methotrexate derivatives |
| 09/26/2001 | EP1135382A1 Method of producing paroxetine hydrochloride |
| 09/26/2001 | EP1135377A1 Novel compounds |
| 09/26/2001 | EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors |
| 09/26/2001 | EP1135367A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
| 09/26/2001 | EP1135164A1 Method for the treatment of inflammation |
| 09/26/2001 | EP1135163A1 Topical compositions comprising ascomycins |
| 09/26/2001 | EP1135152A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier |
| 09/26/2001 | EP1135135A1 Chk1 kinase inhibitors |
| 09/26/2001 | EP1135126A2 Myt1 kinase inhibitors |
| 09/26/2001 | EP1135122A2 Use of amtolmetin guacyl as an antiinflammatory drug |
| 09/26/2001 | EP1135121A2 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain |
| 09/26/2001 | EP1135107A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases |
| 09/26/2001 | EP1003499B1 Diclofenac solution for topical application |
| 09/26/2001 | EP0988033B1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation |
| 09/26/2001 | EP0802922B1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds |
| 09/26/2001 | EP0800505B1 Novel immunotherapeutic aryl amides |
| 09/26/2001 | EP0775141B1 Phenyl xanthine derivatives |
| 09/26/2001 | EP0773932B1 Benzenesulfonamide derivatives used as bradykinine antagonists |
| 09/26/2001 | EP0767796B1 Chemotactic protein |
| 09/26/2001 | EP0762887B1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 09/26/2001 | CN1314999A Modulating multiple lineage kinase proteins |
| 09/26/2001 | CN1314943A Method for producing plants with increased flavonoid and phenolic compound content |
| 09/26/2001 | CN1314910A Adenosine derivatives |
| 09/26/2001 | CN1314893A IL-8 receptor antanonists |
| 09/26/2001 | CN1314814A Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperdines)-butylazols in preparation of a medicament for the treamtent of pain |
| 09/26/2001 | CN1314179A External medicinal liquid for anti-inflammation, relieving pain and removing poison |
| 09/26/2001 | CN1314176A External use medicine for curing rheumatism and rheumatoid disease |
| 09/26/2001 | CN1314161A Medicine for curing rheumatic and rheumatoid diseases and its preparing method |
| 09/26/2001 | CN1314151A Use of AFMK in preparing medicine with free radical cloaning function |
| 09/26/2001 | CN1071759C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and use thereof |
| 09/26/2001 | CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/26/2001 | CN1071576C External application medicinal bag for curing cancerbus ache and incision ache after operation and its preparing method |
| 09/26/2001 | CN1071571C Composition comprising a tramadol material and acetaminophen and its use |
| 09/25/2001 | US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors |
| 09/25/2001 | US6294661 Compounds |
| 09/25/2001 | US6294652 Response regulator |
| 09/25/2001 | US6294574 Compounds and methods for the treatment of inflammatory and immune disorders |
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294568 Antiinflammatory agents and antitumor agents containing the compounds as the active ingredients and cox2 enzyme inhibitors |
| 09/25/2001 | US6294564 Benzimidazoles and benzoxazoles |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294546 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2001 | WO2001069240A1 Assay for agents that induce chemokinesis |
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |
| 09/20/2001 | WO2001068852A2 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | WO2001068845A2 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068679A2 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | WO2001068652A1 Condensed imidazoles as histamine h3 receptor ligands |
| 09/20/2001 | WO2001068651A1 Condensed imidazoles as histamine h3 receptor ligands |
| 09/20/2001 | WO2001068648A1 Substituted beta-carbolines with ikb-kinase inhibiting activity |
| 09/20/2001 | WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | WO2001068634A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 09/20/2001 | WO2001068633A1 2-phenylpyran-4-one derivatives |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 09/20/2001 | WO2001068607A1 Amide compounds and use thereof |
| 09/20/2001 | WO2001068597A1 N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them |
| 09/20/2001 | WO2001068591A1 Carboxylic acid derivatives as ip antagonists |
| 09/20/2001 | WO2001068570A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068569A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068568A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068142A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 09/20/2001 | WO2001068140A2 Opioid formulations |
| 09/20/2001 | WO2001068105A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068083A1 Use of comt inhibitors as analgesics |
| 09/20/2001 | WO2001068071A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 09/20/2001 | WO2001068070A2 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis |
| 09/20/2001 | WO2001068061A1 Ultraviolet-shielding adhesive preparation |
| 09/20/2001 | WO2001068058A1 Multilayer pharmaceutical product for release in the colon |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001027109A3 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 09/20/2001 | WO2001019819A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001015664A3 Coformulation methods and their products |
| 09/20/2001 | WO2001002540A9 Adenoviral vectors for treating disease |
| 09/20/2001 | WO2000047583A9 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 09/20/2001 | WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | US20010023256 Reducing concentration of oxygen metabolites |
| 09/20/2001 | US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 09/20/2001 | US20010022979 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 09/20/2001 | US20010022971 IBD-associated microbial nucleic acid molecules |
| 09/20/2001 | US20010022964 Fast dissolving orally consumable films |
| 09/20/2001 | EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | DE10013029A1 Multilayer formulation for controlled drug release in colon, comprising drug-containing core having inner and outer coatings of acrylic copolymers with quaternary ammonium and anionic groups respectively |
| 09/20/2001 | CA2403679A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403189A1 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 09/20/2001 | CA2403149A1 2-phenylpyran-4-one derivatives |